Clinical Trials Logo

Akinesia clinical trials

View clinical trials related to Akinesia.

Filter by:
  • None
  • Page 1

NCT ID: NCT04974034 Completed - Parkinson Disease Clinical Trials

Movement Disorders Analysis Using a Deep Learning Approach

Start date: June 1, 2019
Phase:
Study type: Observational

Bradykinesia is a key parkinsonian feature yet subjectively assessed by the MDS-UPDRS score, making reproducible measurements and follow-up challenging. In a Movement Disorder Unit, the investigators acquired a large database of videos showing parkinsonian patients performing Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III protocols. Using a Deep Learning approach on these videos, the investigators aimed to develop a tool to compute an objective score of bradykinesia from the three upper limb tests described in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III.

NCT ID: NCT04178200 Not yet recruiting - Anesthesia, Local Clinical Trials

Evaluation of Duration of Anesthesia and Patient Satisfaction After Retrobulbar Block Applied in Cataract Surgery

Start date: December 16, 2019
Phase:
Study type: Observational

It is aimed to determine patient satisfaction (pain assessment during and after the operation) and the initial and total anesthesia durations of eye lid and globe anesthesia after administration of local anesthetic solution only in standard applied volumes (1.5-3 ml). No agents will be added to the local anesthetic agents used in the conventional retrobulbar block in patients who will undergo cataract surgery,

NCT ID: NCT01770145 Completed - Parkinson's Disease Clinical Trials

Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

AM IMPAKT
Start date: December 2012
Phase: Phase 4
Study type: Interventional

This study is designed to assess the effect of APOKYN treatment in rapid and reliable improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or unreliable onset of levodopa (L-dopa) action.